Stock from the company last seven years (1997-2003)
(new stock - for new totals see current list; if Ray gave you a share of stock it is probably listed in givers/traders on next page)
				Prophy Research Corporation
				From Dec 31, 1996
				To Dec 31, 2003
				All shares at $10 each
	In number of shares
Name	1997	1998	1999	2000	2001	2002	2003	total		Reason (sometimes just for the first time you got)
New Goodwill Shares:
Ray Grogan	3,400	1,120	960	860	1,199	1,240	1,520	10,299		Patents, licensing, reports, CEO
Darby Glenn, MD	490	250	250	300	200	200	200	1,890		General leadership now, originator of prenatal F, VP
Tom Peebles, MD	370	200	200	200	200	200	200	1,570		General leadership now, originator of infant F, Chair
Alan Hauser	1							1		Sent a few good papers
Sylvia Pager, MD		3		5	10	10	10	38		"Proportional dosing" phrase; director later
BSA Hans D	13			5	3	2	5	28		Found Belgian OptiDose devices
BSA Gail K	-1							-1		Gave back share
BSA Heinz/Julia B MD	96	100	200	50	30	30	36	542		Swiss patenting and  licensing
BSA Eric L	20	20	20	20	10	10	10	110		South Africa patent help
BSA Ann Q	5	1	1	1				8		Ireland patent help
BSA Dan B				1				1		Dropper and TM graphics
BSA Jeannie M				2				2		Zimecterin sample
BSA Becca M				1				1		Dropper and TM graphics
BSA Paul B							1	1		License request for iron product
PD Betty M	5							5		Cool letter, postcard size report idea
PD Ingolf M	1							1		Fluorosis pix; Fdef=mal & enamel defects data
PD Mark B			1					1		Patent disputes example
Total new Goodwill shrs	4,400	1,694	1,632	1,445	1,652	1,692	1,982	14,497				$20,710	Yearly avg
in dollars =	$44,000	$16,940	$16,320	$14,450	$16,520	$16,920	$19,820	$144,970		(Gets added to patent "values" on balance sheet)
New Hard Asset Shares:
Ray Grogan	269.2	84.7	60.2	75.9	68.9	10.9	194.2	490.0		Expenses
Ray Grogan	60							60		Bank $ deposit
FT (Nancy G)			25					25		Bank $ deposit
BSA (Heinz B)	36	20	60	40				156		Swiss patent expenses
BSA (Eric L)	10	10	10	10				40		S. Africa pat expenses
Total new Hard Asset shrs	375.2	114.7	155.2	125.9	68.9	10.9	194.2	771.0
in dollars =	$3,752	$1,147	$1,552	$1,259	$689	$109	$1,942	$7,710		(Gets added to our paid in capital on balance sheet)
Financials summary  (You get this instead of me mailing tons of accounting statements, etc.)
The effect of this new hard asset stock on our financials is that our balance sheet shows an increase in
paid-in capital. We eat up most of our new capital with our losses (below), and the difference is the change in our cash balance.
Expenses:										Changes	End 2003	Begin 1997
1997	$3,237				Retained losses increase:					$10,222	-$60,849	-$50,627
1998	$1,584				Paid-in capital increase:					$10,450	$61,876	$51,426
1999	$1,327				Difference:					$228
2000	$1,284				Cash balance increase:					$228	$1,027	$799
2001	$  714
2002	$  109				Goodwill patent values increase:					$144,970	$288,270	$143,300
2003	$1,967		Avg		(from above)
total	$10,222		$1,460
(This list of expenses is also our profit and loss stmt, since we had no sales.)
So, a typical year is me spending about $1,500 on fees to the patent office. I re-write our applications one or two times,
and otherwise work maybe half a year. From that I say our patent applications are worth about $20,000 more each year.
Our long term prospects are that either the patents will be worth something, or the whole thing just fades away.
Total new shares:
	4,775	1,809	1,787	1,571	1,721	1,703	2,176	15,268		(Gets added to our total number of shares.)